SURFACtoBioTech GmbH
SURFACtoBioTech is a biotech startup spun off from Max Planck Innovation that develops chemically engineered surfactants optimized for droplet-based microfluidics applications. Their business model includes off-the-shelf surfactant solutions, custom surfactant formulations, and synthesis services tailored to unique biotech experiments. The company aims to disrupt traditional bulk biotech experimentation by enabling efficient, sustainable, and powerful droplet compartmentalized experiments that enhance optimization, statistical power, and resource efficiency. Their technology reduces operational complexity and costs compared to competitors and supports applications such as synthetic cell construction, cell encapsulation, and digital molecular biology. SURFACtoBioTech also plans to develop automation platforms and analytical tools to maximize value from microfluidic droplets and offers consulting and training services to empower researchers globally. The company emphasizes sustainability, inclusivity, and innovation in biotech research, positioning itself as a pioneer in droplet-based biotechnology with a strong scientific and business leadership team.
SURFACtoBioTech GmbH
SURFACtoBioTech is a biotech startup spun off from Max Planck Innovation that develops chemically engineered surfactants optimized for droplet-based microfluidics applications. Their business model includes off-the-shelf surfactant solutions, custom surfactant formulations, and synthesis services tailored to unique biotech experiments. The company aims to disrupt traditional bulk biotech experimentation by enabling efficient, sustainable, and powerful droplet compartmentalized experiments that enhance optimization, statistical power, and resource efficiency. Their technology reduces operational complexity and costs compared to competitors and supports applications such as synthetic cell construction, cell encapsulation, and digital molecular biology. SURFACtoBioTech also plans to develop automation platforms and analytical tools to maximize value from microfluidic droplets and offers consulting and training services to empower researchers globally. The company emphasizes sustainability, inclusivity, and innovation in biotech research, positioning itself as a pioneer in droplet-based biotechnology with a strong scientific and business leadership team.